Chris Chiavatti

Nov 7, 2024 | mondaq.com | Chris Chiavatti

On September 19, 2024, the Supreme Court of Canada granted leave in Pharmascience Inc v Janssen Inc et al ["Janssen"], giving the Supreme Court an opportunity to weigh in whether certain dosing regimens are unpatentable methods of medical treatment in Canada. Canadian case law prevents methods of medical treatment from being patented.

Jun 28, 2024 | mondaq.com | Chris Chiavatti

Is your company involved in clean technology and seeking fast patent protection in Canada, the United States, or further abroad? The Canadian Patent Office has a Green Technologies Program, designed to expedite patent grants for inventions related to clean technology. This program significantly accelerates your patent applications. Moreover, the (PPH) agreement between Canada and the United States allows Canadian patent holders to expedite access to the US market.

Mar 20, 2024 | mondaq.com | Chris Chiavatti |Liz Gray |Carolyn Moore |Stephanie Williams

CONTRIBUTING SINCE FEBRUARY 2024 POPULAR TOPICS Intellectual Property COMPANIES CONTENT

Mar 20, 2024 | mondaq.com | Chris Chiavatti |Liz Gray |Carolyn Moore |Stephanie Williams

CONTRIBUTING SINCE FEBRUARY 2024 POPULAR TOPICS Intellectual Property COMPANIES CONTENT